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MMP-10 Regulates Collagenolytic Activity of
Alternatively Activated Resident Macrophages
Maryam G. Rohani1,2,3, Ryan S. McMahan1,4, Maria V. Razumova5, Angie L. Hertz1,2, Maryelise Cieslewicz5,
Suzie H. Pun5, Michael Regnier5, Ying Wang1,2,3, Timothy P. Birkland1,2 and William C. Parks1,2,3
Matrix metalloproteinase-10 (MMP-10) is expressed by macrophages and epithelium in response to injury, but its
functions in wound repair are unknown. We observed increased collagen deposition and skin stiffness in
Mmp10–/– wounds, with no difference in collagen expression or reepithelialization. Increased collagen
deposition in Mmp10–/– wounds was accompanied by less collagenolytic activity and reduced expression of
speciﬁc metallocollagenases, particularly MMP-8 and MMP-13, where MMP-13 was the key collagenase. Ablation
and adoptive transfer approaches and cell-based models demonstrated that the MMP-10-dependent
collagenolytic activity was a product of alternatively activated (M2) resident macrophages. These data
demonstrate a critical role for macrophage MMP-10 in controlling the tissue remodeling activity of macrophages
and moderating scar formation during wound repair.
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INTRODUCTION
Scar formation, the deposition of ﬁbrous connective tissue
within a wound bed, is a normal consequence of injury and
provides temporary strength to damaged tissue. However,
excessive, persistent scarring can lead to a variety of clinical
problems, such as keloids, hypertrophic scars, and severe
life-threatening ﬁbrosis of lung, kidney, and liver. In these
conditions, excess scarring is seemingly due to both an
overabundance of collagen production and inadequate
resolution (McKleroy et al., 2013).
Although far from being fully understood, resolution of
scarring and ﬁbrosis appears to be the responsibility of
macrophages and, in particular, alternatively activated (M2)
macrophages (Atabai et al., 2009; Madsen et al., 2013).
Current models indicate that matrix turnover involves two
sequential steps: limited extracellular proteolysis followed by
uptake and lysosomal degradation (Madsen et al., 2011). For
the ﬁrst step, some matrix metalloproteinases (MMPs) cleave
the large collagen ﬁbrils into fragments that can be
endocytosed and degraded intracellularly (Lee et al., 2006;
Madsen et al., 2007; Wagenaar-Miller et al., 2007). MMPs
can also contribute to resolution of scarring and ﬁbrosis
indirectly by shaping the proteolytic phenotype of cells
(Giannandrea and Parks, 2014).
In response to injury, stromelysin-2 (MMP-10) is induced by
epithelial cells and macrophages in many organs, including
the skin (Saarialho-Kere et al., 1994; Kassim et al., 2007;
Koller et al., 2012). In collaboration with others, we reported
that overexpression of active MMP-10 in basal keratinocytes
did not affect reepithelialization and led to only a minor
phenotype in basement membrane deposition (Krampert
et al., 2004). The function of MMP-10 during wound repair
remains to be elucidated.
Similar to most tissues, the skin contains a population of
resident macrophages, and following injury additional macro-
phages inﬂux into the wound bed (Jameson et al., 2005).
Macrophages have distinct roles during different phases of
wound repair, but it is not clear how these roles are split
between resident and recruited cells. Macrophages contribute
to scar formation by producing proﬁbrotic cytokines that
activate resident ﬁbroblasts and pericytes into extracellular
matrix–producing myoﬁbroblasts (Dufﬁeld, 2003; Wynn and
Barron, 2010). Depletion of macrophages soon after injury
impairs formation of vascularized granulation tissue and
delays repair (Goren et al., 2009; Lucas et al., 2010). On
the other hand, as demonstrated in liver injury, depletion
of macrophages during later phases leads to an inability to
resolve ﬁbrotic matrix (Dufﬁeld et al., 2005; Ramachandran
et al., 2012). Early-phase macrophages are predominately
classically activated proinﬂammatory cells (M1 biased),
whereas the resolution-phase cells tend to be alternatively
activated, remodeling-competent macrophages (M2 biased)
(Mosser and Edwards, 2008; Lichtnekert et al., 2013).
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Here we report that scarring was increased in wounded
skin of Mmp10–/– mice. We found that excess extracellular
matrix was not associated with increased expression of
collagen but rather with reduced metallocollagenolytic
activity of resident macrophages. As MMP-10 lacks collage-
nolytic activity, these ﬁndings indicate that this proteinase
regulates the extracellular matrix degradative potential of
macrophages.
RESULTS
MMP-10 does not affect reepithelialization
Using RNA from uninjured wild-type mouse skin, we
detected a Ct range for Mmp10 mRNA between 36 and 37
(Supplementary Figure S1 online), indicating essentially no or
very low levels of expression. Similar to that reported earlier
(Krampert et al., 2004), Mmp10 was induced by day 3 after
wounding, remained elevated at day 8, and began to decline
by day 12 (Supplementary Figure S1 online). To examine the
role of MMP-10 in reepithelialization, we compared the rate
of wound closure between wild-type and Mmp10–/– mice
(Supplementary Figure S2 online). However, wound closure
rates (i.e., slope of the lines) did not differ between wild-type
and Mmp10–/– wounds, and both visual (Supplementary
Figure S2 online) and histologic (not shown) analyses showed
complete reepithelialization in both genotypes by day 8 after
injury.
MMP-10 moderates collagen deposition
During wound healing, the granulation tissue is replaced with
newly deposited type I collagen forming a scar. Net collagen
deposition is the sum of syntheses minus turnover. In skin
wounds, collagen production begins 3–5 days after wounding
and peaks around day 10 (Wu et al., 2003). Between days 3
and 8, we observed a trend for more deposition of collagen in
Mmp10–/– wounds compared with wild types (not shown) that
led to signiﬁcantly elevated levels of accumulated collagen
deposition by day 12 in null mice (Figure 1a–c). Consistent
with more collagen deposition, we found, using an estab-
lished method that measures the dynamic mechanical
strength of skin wounds (Jørgensen et al., 1993), that day 12
Mmp10–/– wounds were signiﬁcantly stiffer than wild-type
wounds (Figure 1d). These data indicate that MMP-10
moderates scar formation. In intact skin, collagen levels did
not differ signiﬁcantly between wild-type (155± 26.8 μg per
biopsy) and Mmp10–/– (165.7±26.0) mice.
MMP-10 does not affect collagen mRNA levels
We assessed whether increased collagen deposition in
Mmp10–/– wounds was due to increased synthesis. Basal
levels of Col1a1 mRNA and its increase and decline in res-
ponse to injury did not differ between genotypes (Supple-
mentary Figure S3a online). In addition, we found no
signiﬁcant difference in α-smooth muscle actin protein levels,
a marker of myoﬁbroblasts, the major cell source of collagen
synthesis in scars, between wild-type and Mmp10–/– wounds
at days 3 (not shown), 8, or 12 (Supplementary Figure S3b
online). Furthermore, we found no difference in the prolifera-
tion rate, the basal or transforming growth factor-β1–
stimulated expression of α-smooth muscle actin, or collagen
uptake between primary dermal ﬁbroblasts from wild-type or
Mmp10–/– mice (Supplementary Figure S4 online).
MMP-10 promotes collagen degradation
The above data indicate that increased deposition in
Mmp10–/– wounds was due to impaired turnover. In deﬁned,
in vitro degradation assays, MMP-10 does not cleave native
type I collagen (Sternlicht and Werb, 2001; Parks et al., 2004).
Thus, we assessed whether MMP-10 inﬂuences the overall
collagenolytic activity in wounds. For this, wound samples
were incubated with quenched-ﬂuorescent type I collagen
(DQ collagen), and release of ﬂuorescence was measured as
an indicator of total collagenase activity. Indeed, signiﬁcantly
less collagenase activity was released from Mmp10–/–wounds
compared with wild-type samples (Figure 2a).
We used biopsies of intact skin as an ex vivo injury model
(Dumin et al., 2001). In wild-type explants, induction of
Mmp10 mRNA was detected at 72 hours after biopsy (Supple-
mentary Figure S5a online), similar to the in vivo pattern
(Supplementary Figure S1 online). Using both DQ and native
type I collagens, we found that signiﬁcantly less collagenase
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Figure 1. Matrix metalloproteinase-10 (MMP-10) moderates collagen
accumulation at the site of injury. (a) Uniform 8mm wound samples were
collected on day 12 after injury, and hydroxyproline was quantiﬁed and
normalized per wound sample (n= 8 mice per genotype); *Po0.05.
(b) Representative images of day 12 wounds stained with Masson’s trichrome.
Scale bar= 100 μm. (c) Quantiﬁcation of collagen density in Masson’s
trichrome–stained samples. Data are the ratio of collagen-positive (blue) area
to total surface area (SA). Each point represents samples from an individual
mouse. (d) Tissue stiffness of wounds was measured using 12-day wound
samples. Data are presented as the amount of force change per
percent of length change. (n= 4 WT, 3 Mmp10–/–), *Po0.05. WT, wild type.
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activity was released from Mmp10–/– explants compared with
wild-type samples (Figure 2b and c). The levels of collagenase
activity released from wild-type and Mmp10–/– tissues and
the differences between genotypes were comparable for both
wound samples and explants (Figure 2a and b). Because
recruited inﬂammatory cells are not present in explants, the
close similarity in the data between these models indicates
that the MMP-10-dependent collagenase activity was a
product of cells residing in intact skin.
To identify the nature of the reduced collagenolytic activity,
we treated wound samples with GM6001, a broad-spectrum
metalloproteinase inhibitor. In the presence of GM6001,
collagenase activity was reduced to the same level in both
genotypes (Figure 2d), indicating that MMP-10 promoted the
expression and/or activity of a metallocollagenase(s). Addition
of active recombinant human MMP-10 increased the level of
collagenase activity released from Mmp10–/–explants but had
no effect on the activity from wild-type samples (Figure 2e).
Conﬁrming its lack of collagenase activity, recombinant
human MMP10 did not release ﬂuorescence from DQ
collagen (not shown).
MMP-10 controls expression of collagenolytic MMPs
These data indicate that MMP-10 moderates scar formation
and promotes resolution by controlling metallocollagenase
activity. To identify the speciﬁc enzyme(s), we assessed
the expression of mRNAs for Mmp2, 8, 9, 13, 14, and 16
that encode known or suspected collagenases (Shi et al.,
2008; Sabeh et al., 2009). In day 3 wound samples, we
found reduced expression of Mmp8 and Mmp9 mRNAs in
Mmp10–/– samples (Figure 3). In day 8 wound samples, the
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Figure 2. Reduced collagenase activity in Mmp10–/– wounds. (a) Day 8
wounds were incubated with DQ collagen for 72 hours. Collagen degradation
was measured every 24 hours (n= 3 per genotype). (b) Collagenase activity
from explants of normal skin (n=7 wild type (WT), 6 Mmp10–/–). (c) Skin
explants were seeded on FITC-conjugated type I collagen gels. Collagenase
activity was measured in conditioned medium at 72 hours (n=5 per
genotype). (d) Explants were incubated with 25 μM GM6001, and collagenase
activity was assessed 72 hours later (n=4 WT, 3 Mmp10–/–). (e) Explants were
treated with recombinant human (rh)-MMP-10 (100 ngml−1) or vehicle
(control (Ctrl)), and collagenase activity was assessed 72 hours later
(n= 5 per genotype). *Po0.05, **Po0.01, ***Po0.001, and ****Po0.0001.
MMP-10, matrix metalloproteinase-10; NS, not signiﬁcant.
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Figure 3. Matrix metalloproteinase-10 (MMP-10) inﬂuences expression of collagenolytic MMPs. Expression of mRNAs for Mmp2, 8, 9, 13, 14, and 16 was
quantiﬁed in wound samples harvested at the indicated days. Data shown are the ratios compared with nonwounded wild-type (WT) samples and normalized to
Hprt (n≥ 4 per genotype). *Po0.05, ***Po0.001, and ****Po0.0001. RQ, relative quantiﬁcation.
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levels of Mmp2, Mmp13, and Mmp14 mRNAs were signiﬁ-
cantly lower in Mmp10–/– mice (Figure 3). Similarly,
in explants, we found that Mmp8, Mmp9, and Mmp13
mRNAs were signiﬁcantly reduced in Mmp10–/– samples
(Supplementary Figure S5 online). These results suggest that
reduced expression of speciﬁc collagenolytic MMPs con-
tributed to increased collagen accumulation in Mmp10–/–
wounds.
MMP-10 does not impact macrophage inﬂux into skin wounds
To analyze the cellular mechanism by which MMP-10
governs collagen cleavage, we focused on macrophages.
Although the similar levels of activity released from wound
biopsies and explants (Figure 2) suggested that MMP-10-
dependent collagenolysis was a function of resident cells,
impaired inﬂux of macrophage could also have contributed to
reduced collagenase activity inMmp10–/– wounds. However,
we found no difference in the number of resident macro-
phages between wild-type andMmp10–/–skin (Supplementary
Figure S6a and b online) or in the total number of
macrophages (resident plus recruited) in wild-type and
Mmp10–/–wounds (Supplementary Figure S6c and d online).
Furthermore, we detected no difference in the ability of wild-
type and Mmp10–/– macrophages to migrate toward serum
(Supplementary Figure S6e online) or in macrophage chemo-
tactic activity in wild-type and Mmp10–/– wounds
(Supplementary Figure S6f online). These data indicate that
the reduction in collagenase activity in Mmp10–/– wounds
was not due to fewer macrophages.
MMP-10 modulates collagenolytic activity of alternatively
activated macrophages
To assess a functional role for macrophages, we depleted
these cells in explants using clodronate liposomes
(Supplementary Figure S7a online). Whereas depletion of
macrophages in wild-type explants signiﬁcantly reduced total
collagenase activity to the levels seen in Mmp10–/– samples,
ablation did not further lower the reduced activity in
Mmp10–/– tissue (Figure 4a). Skin-resident macrophages are
categorized as alternatively activated (M2) cells (Davies et al.,
2013), and M2 macrophages are considered to be the cells
responsible for tissue remodeling (Madsen et al., 2013).
Hence, we selectively ablated M2-like macrophages using the
M2pepKLA fusion peptide (Cieslewicz et al., 2013). The
effectiveness of M2pepKLA was conﬁrmed by reduced levels
of MRC-1 (Supplementary Figure S7b online), an M2
macrophage marker. Similar to the clodronate data, ablation
of M2 macrophages with M2pepKLA signiﬁcantly decreased
collagenase activity in wild-type explants but not in
Mmp10–/– samples (Figure 4b).
The macrophage ablation data indicated that MMP-10
inﬂuenced the expression of collagenolytic MMPs in M2
macrophages. To test this idea, we isolated bone marrow–
derived macrophages (BMDMs) from wild-type and
Mmp10–/– mice and assessed the expression of collagenolytic
MMPs in naive (M0) and M1- and M2-differentiated cells.
Although the expression levels of metallocollagenases
differed between M0 and M1 macrophages, these cell
subtype–speciﬁc expression patterns did not differ between
wild-type and Mmp10–/– cells (Supplementary Figure S8
online). However, we did ﬁnd reduced expression of Mmp8
and Mmp13 mRNAs and elevated levels of Mmp9 in
Mmp10–/– M2 macrophages (Figure 5a). These data agree
with the reduced expression of Mmp8 and Mmp13 in
Mmp10–/– wounds (Figure 3) and explants (Supplementary
Figure S5b online). Antibody clearance demonstrated that
MMP-13 accounted for the bulk of collagenase activity
produced by wild-type M2 macrophages (Figure 5b).
Furthermore, polarization to M2-like macrophages
increased the collagenase activity released from wild-type
macrophages but had no effect on the activity released from
Mmp10–/–macrophages (Figure 5c). Expression of Arg1 and
Fizz1 increased markedly in M2-differentiated macrophages
(Gordon, 2003), but this well-characterized M2 response was
not altered in Mmp10–/– cells (Supplementary Figure S9
online). These data indicate that the reduced levels of
collagenase activity released fromMmp10–/– M2 macrophage
were independent of the ability of Mmp10–/– M0 macro-
phages to respond to the M2 agonists.
To demonstrate that reduced collagenolytic activity of
macrophages contributed to enhanced scarring in Mmp10–/–
wound, we transferred BMDMs from wild-type MacGreen
mice into Mmp10–/– recipients on day 10 after injury. Tissues
were harvested 2 days later (day 12 after wounding). EGFP+
macrophages were detected in both wild-type and Mmp10–/–
wounds (Supplementary Figure S10 online), and similar
numbers of F4/80+ macrophages were detected in wounds
from both genotypes (Figure 6a and b). We found that the
inﬂux of wild-type macrophages normalized the increased
collagen deposition seen in Mmp10–/– wounds (Figure 6c).
DISCUSSION
We report that macrophage-derived MMP-10 serves a
beneﬁcial role in tissue repair by promoting resolution of
scar tissue. Our ﬁndings indicate MMP-10 shaped scar
deposition indirectly by controlling the collagenolytic activity
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Figure 4. Matrix metalloproteinase-10 (MMP-10) regulates collagenase
activity of tissue macrophages. Wild-type (WT) and Mmp10–/– skin explants
were cultured in the upper chambers of a 24-transwell plate containing
(a) phosphate-buffered saline (PBS) or clodronate liposomes (n=3 per
genotype) or (b) the apoptosis-inducing peptide M2pepKLA or
ScrM2peptideKLA (20 μgml−1; n=5 per genotype). FITC-conjugated type I
collagen was added to the medium in the lower chamber, and collagenase
activity was measured 72 hours later. **Po0.01. NS, not signiﬁcant.
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of M2-biased resident macrophages without affecting col-
lagen production by ﬁbroblasts/myoﬁbroblasts. More speciﬁ-
cally, we found that MMP-10, which is not a collagenase,
promoted the expression of MMP-8 and MMP-13, two
metallocollagenases released by macrophages. However,
we found that essentially all collagenolytic activity was due
to MMP-13, suggesting that macrophage-derived MMP-8
functions in other processes. Indeed, data supporting that
MMP-8 functions as a collagenase are not compelling. Both
overexpression and deletion of Mmp8 reduce ﬁbrosis (Siller-
Lopez et al., 2004; Garcia-Prieto et al., 2010; Craig et al.,
2013).
Studies with Mmp13–/– mice complement our conclusions.
The resolution of CCl4-induced liver ﬁbrosis is slowed down
in Mmp13–/– mice (Fallowﬁeld et al., 2007) and accelerated
in mice overexpressing this collagenase (Yang et al., 2014),
and both of these studies linked MMP-13 production to scar-
associated macrophages. Furthermore, excess type I collagen
is deposited in the bones of Mmp13–/– mice (Inada et al.,
2004; Stickens et al., 2004). On the other hand, liver ﬁbrosis
due to bile duct ligation is reduced in Mmp13–/– mice
(Uchinami et al., 2006). Regarding skin wounds, disparate
ﬁndings have been reported for phenotypes in Mmp13–/–
mice. Whereas Hattori et al. (2009) concluded that MMP-13
promotes closure of skin wounds, Hartenstein et al. (2006)
found no difference in reepithelialization between wild-type
and Mmp13–/– mice. Although neither skin wound study
assessed scarring directly, Hattori et al. (2009) reported a
reduction in both wound contraction and myoﬁbroblast
numbers in Mmp13–/– mice, ﬁndings that would suggest
that MMP-13 has proﬁbrotic activities too. As MMP-13 is
expressed by many cells types, it is likely that this MMP
can affect multiple, distinct processes within and among
models.
Our ﬁndings indicate that MMP-10 controls collagen
turnover by macrophages by promoting the expression of
speciﬁc metallocollagenases, primarily MMP-13. As MMP-13
levels were reduced but not absent in Mmp10–/– macro-
phages, the residual enzyme likely contributed to the
collagenase activity in Mmp10–/– samples and cells and
may explain why we did not observe any differences in
granulation tissue formation as seen in mice with a complete
lack of MMP-13 (Toriseva et al., 2012). Complementary to
our conclusion, the transcription factor ANKRD1 inﬂuences
expression of Mmp13 and Mmp10 (Almodovar-Garcia et al.,
2014), suggesting a link in the synthesis of these two MMPs.
In our studies, we used a model of normal skin repair, and
we observed no differences in macrophage inﬂux or in the
expression of α-smooth muscle actin and type I collagen (or
other markers of ﬁbroblast activation) between wild-type and
Mmp10–/– mice. In contrast, macrophage inﬂux, α-smooth
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muscle actin expression, and ﬁbrosis are elevated in
Mmp10–/– mice in models of severe liver (Garcia-Irigoyen
et al., 2013), colon (Koller et al., 2012), and lung injury
(Parks et al., unpublished ﬁndings). Although an explanation
for these disparate ﬁndings is not yet apparent, we propose
that the mechanisms by which MMP-10 affects ﬁbrosis and
macrophage inﬂux are context dependent. Thus, the profound
proinﬂammatory responses in liver/colon/lung models may
lead to MMP-10-dependent roles in macrophage recruitment
and activation that, in turn, stimulate myoﬁbroblast differ-
entiation and collagen production. In contrast, because the
inﬂammatory response is less profound in skin wounds,
MMP-10-dependent controls on macrophage inﬂux could
be modest and, hence, not easily detected in Mmp10–/–
tissues.
Compared with the evidence supporting their roles in
promoting ﬁbrosis (Pellicoro et al., 2014), there are limited
data on how macrophages function during resolution. We
found that MMP-10 shapes the tissue-remodeling function
of resident skin M2-like macrophages (Davies et al., 2013)
by regulating expression of MMP-13. Reduced levels of
this metallocollagenase were consistently seen among wound
biopsies (Figure 3), explants (Supplementary Figure S5b
online), and M2-polarized cultured macrophages (Figure 5a).
Reparative or M2-like macrophages are the dominant popula-
tion of macrophages during the resolution phase (Lichtnekert
et al., 2013; Dufﬁeld, 2014). M0 macrophages possessed
baseline collagenolytic activity (Figure 5c), and treatment with
M2 agonists led to a signiﬁcant increase in the overall
collagenase activity released by wild-type macrophages but
had no effect on the levels fromMmp10–/– cells. These ﬁndings
support our central conclusion that MMP-10 controls the
collagenolytic activity of M2-biased macrophages. In agree-
ment with our ﬁndings, Madsen et al. (2013) demonstrated that
M2-like macrophages are the principal cells executing
collagen turnover in the skin.
Our ﬁndings indicated that M2-biased resident macro-
phages were responsible for scar resolution in excisional skin
wounds. Of note, induction of Arg1 and Fizz1, the commonly
used M2 markers, was not altered in IL-4/IL-13-treated
Mmp10–/– macrophages, but a key function––tissue remodel-
ing––attributed to this type of macrophage was markedly
impaired. These ﬁndings add to the many caveats of the M1/
M2 classiﬁcation scheme and underscore that function is
more important in deﬁning macrophage subtype than
expression of a few markers (Murray et al., 2014).
Excess scarring (ﬁbrosis) can affect quality of life, with loss
of tissue function, restriction of movement, and adverse
psychological consequences (Brown et al., 2008). Although
ﬁbrotic conditions are oft considered to be irreversible, an
understanding of how macrophage activation is controlled
and how excess extracellular matrix is cleared will shed light
on the means to manipulate these severe diseases. Results
from our study demonstrate a role for MMP-10 in controlling
the ability of M2-like macrophages to degrade ﬁbrillar
collagen during repair of skin wounds. Whether MMP-10
has a similar, beneﬁcial role in mitigating ﬁbrosis in disease
settings has yet to be determined.
MATERIALS AND METHODS
Animals
Mmp10–/– mice (C57BL/6J) (Kassim et al., 2007) and wild-type
littermates (male and female) were used for these studies. All
procedures were approved by the Ofﬁce of Animal Welfare,
University of Washington, and the institutional animal care and use
committee, Cedars-Sinai.
Wounds and explants
Mice were anesthetized, and their dorsal surface was shaved. The
skin was pulled into a fold and laid on a plastic surface. Two full-
thickness wounds were created by running a sterile 5-mm punch
biopsy (Miltex, New York, NY) through the fold. Four wounds were
made per mouse and left uncovered. Mice were housed in individual
cages. On indicated days after injury, wounds were excised with an
8-mm biopsy punch for further analysis.
RNA
Total RNA was isolated, and speciﬁc transcripts were quantiﬁed
by quantitative real-time PCR using TaqMan FAM-labeled probes
(Applied Biosystems, Foster City, CA) as previously described (Rohani
et al., 2014).
Hydroxyproline
Excised wounds were weighed and homogenized in deionized
water (20 μl per mg tissue). Equal volumes of homogenates were mixed
with 12N HCl (1:1) and hydrolyzed for 3 hours at 120 °C. Hydroxypro-
line was measured using a colorimetric assay (BD BioVision, Milpitas,
CA). Data are presented as total μg hydroxyproline/biopsies.
Histology
Sections (4 μm) of parafﬁn-embedded tissues were stained with
Masson’s trichrome or processed for immunohistochemistry with anti
F4/80 (BM8, eBioscience, San Diego, CA). VisioPharm software
(Hørsholm, Denmark) was used to quantify the total area of F4/80
signal or trichrome staining, normalized to total surface area.
Biomechanics
Skin stiffness was measured as previously described (Rohani et al.,
2014). Brieﬂy, 12-day wound samples were dissected into strips and
suspended on hooks attached to a force transducer (Aurora Scientiﬁc,
model 400A, Aurora, ON, Canada) and a length controller (Aurora
Scientiﬁc, model 308B). Tissue stiffness (dF/dL) was determined by
imposing change in length of the skin strip and measuring the
resultant change in force normalized per mm of sample width. On
each strip of tissue, 4 steps of 5% length stretches were taken every
30 seconds. Force and length signals were analyzed using custom
LabView software (National Instruments, Austin, TX).
Collagenase
Wound and explant samples were placed in the upper chambers of
transwells in 50 μl, and 1% (v/v) quenched ﬂuorescein-conjugated
DQ type I collagen (1 μg ml−1; Life Technologies, Grand Island, NY)
was added to the bottom chambers in 500 μl of phenol red-free RPMI
with 1% fetal bovine serum and 1% penicillin/streptavidin.
Collagenase activity was deﬁned as the ﬂuorescence detected in
the bottom chamber (excitation 480 nm and emission 530 nm) minus
ﬂuorescence in blank controls (no sample in the upper chamber). For
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3D matrix, we mixed native type I collagen (PurCol, Advanced
BioMatrix, Carlsbad, CA) with DQ collagen and seeded explants
onto the mixed matrix and assessed collagenase activity. For
antibody depletion, we cultured samples with antibodies against
MMP-8 (R&D Systems, Minneapolis, MN) or MMP-13 (Thermos
Fisher Scientiﬁc, Waltham, MA). For macrophages, cells were
incubated with phenol red-free RPMI containing 1% DQ collagen
for 6 hours.
Macrophage depletion
Explants were cultured for 72 hours with phosphate-buffered saline
or clodronate liposomes (50mgml−1; http://www.clodronatelipo
somes.org) added to the upper chamber. To deplete M2 macro-
phages, explants were cultured with 20 μg ml−1 M2pepKLA or a
control scrambled peptide (scrM2pepKLA) (Cieslewicz et al., 2013).
Macrophage culture
Isolation and activation of BMDMs were done as previously
described (Manicone et al., 2009). Brieﬂy, marrow cells were
cultured for 7 days in Mac medium. For M2 activation, BMDMs
were stimulated with 10 ngml−1 IL-4 and IL-13 for 48 hours. For M1
activation, cells were cultured with 100 ngml−1 E. coli lipopoly-
saccharide for 6 hours, washed, and cultured for another 24 hours.
For adoptive transfer, macrophages were collected at day 5 after
marrow harvest and suspended in phosphate-buffered saline.
Recipient mice received 7× 106 BMDMs in 50 μl phosphate-
buffered saline via retro-orbital injection.
Statistical analysis
Statistical analysis was performed using Prism 5 (GraphPad Software,
La Jolla, CA). We used t-test to compare two groups or two-way
analysis of variance followed by Bonferroni post-test to test the effect
of two factors. Data are presented as mean± SEM. A P-value of
o0.05 was considered statistically signiﬁcant.
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